ATE40698T1 - PEPTIDES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS. - Google Patents

PEPTIDES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS.

Info

Publication number
ATE40698T1
ATE40698T1 AT84101001T AT84101001T ATE40698T1 AT E40698 T1 ATE40698 T1 AT E40698T1 AT 84101001 T AT84101001 T AT 84101001T AT 84101001 T AT84101001 T AT 84101001T AT E40698 T1 ATE40698 T1 AT E40698T1
Authority
AT
Austria
Prior art keywords
leu
arg
preparation
pharmaceutical compositions
peptides
Prior art date
Application number
AT84101001T
Other languages
German (de)
Inventor
Shinro Tachibana
Shizuko Ohya
Yoshihiro Arakawa
Takahiro Nakazawa
Takeru Kaneko
Masuhiro Ikeda
Kiyomi Yamatsu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of ATE40698T1 publication Critical patent/ATE40698T1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A novel peptide having the primary structure: N-Me-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-D-Ile-Arg-Pro-Lys-D-Leu-Lys-Trp-NH<sub>2</sub> (in which D · lie and D b.Leu represent a D-Ile and a D-Leu residue respectively, other abbreviations of amino acids represent each an L-amino acid residue and Me represents a methyl group), which exhibits a remarkable analgesic effect when administered peripherally. A process for the preparation thereof by a solid phase method and pharmaceutical compositions containing said peptide are also disclosed.
AT84101001T 1983-02-01 1984-02-01 PEPTIDES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS. ATE40698T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58013785A JPS59141547A (en) 1983-02-01 1983-02-01 Novel peptide having analgesic action and its preparation
EP84101001A EP0115850B1 (en) 1983-02-01 1984-02-01 Novel peptide, process for the preparation thereof and pharmaceutical composition containing said peptide

Publications (1)

Publication Number Publication Date
ATE40698T1 true ATE40698T1 (en) 1989-02-15

Family

ID=11842901

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84101001T ATE40698T1 (en) 1983-02-01 1984-02-01 PEPTIDES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS.

Country Status (6)

Country Link
US (1) US4551273A (en)
EP (1) EP0115850B1 (en)
JP (1) JPS59141547A (en)
AT (1) ATE40698T1 (en)
CA (1) CA1248089A (en)
DE (1) DE3476666D1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0680079B2 (en) * 1984-11-09 1994-10-12 エーザイ株式会社 Polypeptide
US5166916A (en) * 1988-12-14 1992-11-24 Asahi Kogaku Kogyo Kabushiki Kaisha Automatic gain control apparatus
DK2253614T3 (en) 2004-04-07 2013-01-07 Novartis Ag IAP inhibitors
PE20110220A1 (en) 2006-08-02 2011-04-11 Novartis Ag DERIVATIVES OF 2-OXO-ETHYL-AMINO-PROPIONAMIDE-PYRROLIDIN-2-IL-SUBSTITUTED AS INHIBITORS OF THE BINDING OF THE PROTEIN Smac TO THE INHIBITOR OF THE PROTEIN OF APOPTOSIS
CN109021073B (en) * 2018-08-30 2021-09-24 陕西师范大学 A modified version of the analgesic peptide HT2 from the Qinling tree frog, HT12 and its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH14681A (en) * 1977-11-30 1981-11-10 Pfizer Phenylglycinamides useful in the treatment of ischaemic heart disease
DE2960258D1 (en) * 1978-03-02 1981-05-07 Akzo Nv Psychopharmacological peptides, process for their preparation and their pharmaceutical formulations
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
JPS57118563A (en) * 1981-01-14 1982-07-23 Takeda Chem Ind Ltd Indole derivative and preparation of peptide
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs

Also Published As

Publication number Publication date
JPS59141547A (en) 1984-08-14
EP0115850A2 (en) 1984-08-15
EP0115850A3 (en) 1987-02-04
US4551273A (en) 1985-11-05
DE3476666D1 (en) 1989-03-16
CA1248089A (en) 1989-01-03
EP0115850B1 (en) 1989-02-08

Similar Documents

Publication Publication Date Title
AU6819294A (en) Oral drug delivery compositions and methods
ES8203385A1 (en) N-(vinblastinoyl-23) derivatives of amino acids and peptides and their preparation.
EP0528312A3 (en) Cyclic peptides and use thereof
ATA195788A (en) TRIPEPTIDES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL108851A (en) Polypeptide bombesin antagonists, their preparation and pharmaceutical preparations containing them
KR840009069A (en) Method for producing psychotropic peptides
Meienhofer et al. Solid-phase synthesis of [8-arginine]-vasopressin through a crystalline protected nonapeptide intermediate and biological properties of the hormone
PT81345B (en) METHOD FOR PREPARING NEW ACTIVE PEPTIDEES ON THE CENTRAL NERVOUS SYSTEM WITH ACTION ON THE COLINERGIC SYSTEM, AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS
ATE40698T1 (en) PEPTIDES, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS.
EP0246795A3 (en) Synthetic natriuretic peptides
ZA943920B (en) Pharmaceutical compositions
MY103251A (en) Biologically active molecules
DE353565T1 (en) IMMUNOSTIMULATING PEPTIDES, THEIR METHOD FOR THE PRODUCTION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
US4579841A (en) Dipeptide derivatives having opiate activity
DE68906572D1 (en) PEPTIDES WITH INHIBITORIC EFFECT ON ENZYMATIC SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ATE15209T1 (en) PROCESS FOR THE PREPARATION OF CARBONICAMIDE GROUP-CONTAINING COMPOUNDS, IN PARTICULAR PEPTIDES.
KR900701830A (en) Novel pentapeptides and methods for their preparation
ATE19777T1 (en) PYRIDOBENZODIAZEPINONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICALS CONTAINING THESE COMPOUNDS.
ATE91286T1 (en) VESSEL ACTIVE PEPTIDES.
DE3585936D1 (en) BIOLOGICALLY ACTIVE PEPTIDES, THEIR METHOD FOR THE PRODUCTION AND PHARMACEUTICAL COMPOSITIONS.
ATE46173T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
DE69304156D1 (en) Novel peptide derivatives effective in the process of cell adhesion, processes for their preparation and pharmaceutical compositions containing them
DE3586752D1 (en) METHOD FOR PRODUCING Wounds Healing Promotional Preparations and Such Preparations.
DE69921011D1 (en) New (3,4,7,8,9,10) hexahydro-6, 10-dioxo-6H-pyridazino / 1, 2-a / / 1, 2 / diazepine-1-carboxylic acid derivatives, process for their preparation and their use in the manufacture of active pharmaceutical ingredients
DE68909451D1 (en) PEPTIDES WITH INHIBITORIC EFFECT ON ENZYMATIC SYSTEMS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee